This is a preview of subscription content, log in via an institution to check access.
Reference
Hernandez I, et al. Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018. JAMA: the Journal of the American Medical Association 323: 854-862, No. 9, 3 Mar 2020. Available from: URL: http://dx.doi.org/10.1001/jama.2020.1012
Rights and permissions
About this article
Cite this article
"Substantial" increases in list and net prices of branded drugs in the US. PharmacoEcon Outcomes News 849, 2 (2020). https://doi.org/10.1007/s40274-020-6653-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6653-4